PRAX Earnings & Financial Statements
Praxis Precision Medicines, Inc.
$248.24
+$9.22(+3.86%)
28
Overall
40
Value
9
Tech
36
Quality
Market Cap
$6.67B
Volume
594.53K
52W Range
$50.56 - $392.70
Target Price
$637.68
PRAX earnings and financial statements: Praxis Precision Medicines, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
PRAX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | $8.55M | $2.45M | - | - |
| Operating income | -$326.20M | -$200.16M | -$126.37M | -$214.99M | -$167.33M |
| EBITDA | -$301.70M | -$181.53M | -$122.01M | -$214.57M | -$167.15M |
| Net income | -$303.30M | -$182.82M | -$123.28M | -$214.03M | -$167.06M |
| EPS (diluted) | $-13.48 | $-10.21 | $-18.69 | $-69.60 | $-59.10 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $937.91M | $483.11M | $87.95M | $115.13M | $292.75M |
| Total liabilities | $59.77M | $37.66M | $18.28M | $39.02M | $41.94M |
| Shareholders’ equity | $878.14M | $445.45M | $69.67M | $76.11M | $250.81M |
| Cash and equivalents | $357.33M | $215.37M | $81.30M | $61.62M | $138.70M |
| Long-term debt | - | $110.0K | $1.37M | $2.50M | $3.50M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$249.07M | -$131.76M | -$111.14M | -$185.04M | -$124.55M |
| Capital expenditure | -$56.0K | - | -$50.0K | -$444.0K | -$1.05M |
| Free cash flow | -$249.12M | -$131.76M | -$111.19M | -$185.49M | -$125.60M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRAX | $248.24 | +3.9% | 594.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Praxis Precision Medicines, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW